Quality of life analysis of TORCH, a randomized trial testing first-line erlotinib followed by second-line cisplatin/gemcitabine chemotherapy in advanced non-small-cell lung cancer.

Details

Language :

English

ISSN :

15560864

Volume :

7

Issue :

12

Database :

Complementary Index

Journal :

Journal of Thoracic Oncology

Publication Type :

Academic Journal

Accession number :

108019545

Full Text :

https://doi.org/10.1097/JTO.0b013e318275b327